https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.biocentury.com%2Farticle%2F658597 2026-03-04 https://www.globalbioaccess.com/news-1/https%3A%2F%2Falveustx.com%2Fnews%2Falveus-therapeutics-announces-fda-clearance-of-ind-and-first-patient-dosed-in-phase-1b-trial-of-alv-100-for-obesity%2F 2026-03-02 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fpharmatimes.com%2Fnews%2Facesion-pharma-launches-phase-2-trial-of-ap31969-in-atrial-fibrillation%2F 2026-03-02 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2026%2F02%2F24%2F3243418%2F0%2Fen%2Falveus-therapeutics-announces-second-and-final-closing-of-oversubscribed-series-a-bringing-total-financing-to-197-million-to-advance-next-generation-therapies-for-obesity-and-metab.html 2026-03-02 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20260224232925%2Fen%2Fcartography-biosciences-doses-first-patient-in-phase-1-trial-of-cbi-1214-a-highly-specific-t-cell-engager-for-the-treatment-of-colorectal-cancer 2026-03-02 https://www.globalbioaccess.com/news-1/https%3A%2F%2Facesionpharma.com%2Facesion-pharma-announces-initiation-of-phase2-trial%2F 2026-03-04 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fendpoints.news%2Fcartography-does-another-pharma-deal-this-time-with-pfizer%2F%3Fu%3Dab0d463c-6575-42e1-8bc6-4d7479bbb9e1%26s%3Demail%26c%3D79153abc-2ae9b617-5eb3214e%26utm_medium%3Demail%26utm_campaign%3D2360%2520-%2520the%2520first%2520biotech%2520acquisition%2520of%25202026%2520protagonists%2520robin%2520hood%2520plan%2520enterprise%26utm_content%3D2360%2520-%2520the%2520first%2520biotech%2520acquisition%2520of%25202026%2520protagonists%2520robin%2520hood%2520plan%2520enterprise%2Bcid_4f31ae94380b138bc8daa8529a9fc356%26utm_source%3Dendpoints%2520emails%26utm_term%3Dcartography%2520does%2520another%2520pharma%2520deal%2520this%2520time%2520with%2520pfizer 2026-01-08 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fendpoints.news%2Fa-year-after-collaborating-with-gilead-cartography-maps-out-its-own-phase-1-with-67m-series-b%2F 2025-10-06 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.prnewswire.com%2Fapac%2Fnews-releases%2Fshiratronics-announces-positive-12-month-follow-up-results-from-reliev-cm-pilot-study-demonstrating-sustained-clinical-benefit-with-investigational-implantable-neuromodulation-therapy-for-chronic-migraine-302555432.html 2025-09-26 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.fiercebiotech.com%2Fspecial-reports%2Fintroducing-fierce-biotechs-2025-fierce-15 2025-10-06 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fodyssey-tx%2Fposts%2F%3Ffeedview%3Dall 2025-09-10 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.mychesco.com%2Fa%2Fnews%2Fregional%2Fvittoria-biotherapeutics-to-present-viper-101-phase-1-trial-at-2025-asco-annual-meeting%2F%23google_vignette 2025-06-09 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.nuvigtherapeutics.com%2Fnuvig-therapeutics-announces-first-patient-dosed-in-phase-2-cidp-trial-of-nvg-2089-and-presentation-of-phase-1-data%2F 2025-06-09 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.forbes.com%2Fsites%2Fjuergeneckhardt%2F2025%2F04%2F23%2Ftreating-autoimmune-diseases-four-new-technologies-to-watch 2025-06-09 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.ddw-online.com%2Fwho-should-we-be-watching-on-the-usa-biotech-stage-34413-202504%2F 2025-06-09 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fepsilogen.com%2Fepsilogen-announces-acquisition-of-tigatx-inc-to-create-worlds-leading-pan-isotype-cancer-antibody-company%2F 2025-05-07 https://www.globalbioaccess.com/news-1/https%3A%2F%2Fwww.bizjournals.com%2Fsanfrancisco%2Fsubscriber-only%2F2025%2F03%2F21%2Fthe-most-funded-women-led-life-sciences-companies-in-the.html 2025-05-07 https://www.globalbioaccess.com/news-1/rmg-kb-bioaccess-fund-launches-with-worldwide-focus-on-innovative-life-sciences-ventures-(prnewswire.com) 2025-05-07 https://www.globalbioaccess.com/news-1/5-most-promising-fintech-startups 2025-09-22 https://www.globalbioaccess.com/news-1/gadget-review%3A-release-of-new-airy-pods 2025-05-07 https://www.globalbioaccess.com/news-1/best-smart-wearables-of-2023 2025-05-07 https://www.globalbioaccess.com/news-1/how-technology-can-help-curb-attention-disorders 2025-05-07 https://www.globalbioaccess.com/news-1/entering-a-new-era-of-iot 2025-05-07 https://www.globalbioaccess.com/news-1/long-term-benefits-of-clean-energy-sources 2025-05-07